Long-Term Use of Bonviva® for the Treatment of Postmenopausal Osteoporosis: New Evidence
Journal Title: Біль. Суглоби. Хребет - Year 2013, Vol 1, Issue 9
Abstract
Osteoporosis is a disease of great social importance. Its treatment is a complicated problem and is associated with low compliance and a risk for adverse reactions. Ibandronate belongs to a group of bisphosphonates. The performed trials have proven the efficacy of its two formulations (a tablet once monthly and intravenous injection once every 3 months) in reducing the risk of bone fractures. At present there are data on trials of long-term therapy with this drug, which demonstrate its positive effect on bone mineral density and bone metabolism markers. In addition, high safety of the drug has been shown in long-term use.
Authors and Affiliations
O. B. Yershova, K. Yu. Belova, A. V. Nazarova
Keywords
Related Articles
- EP ID EP232504
- DOI -
- Views 70
- Downloads 0
Vitamin D and osteoarthritis
The attention of researchers and clinicians is drawn to vitamin D. It is a steroid hormone with a pluripotent mechanism of action, the targets of which, along with other organs and tissues, are articular cartilage and bo...
Clinical Case of Pseudarthrosis of the Tibia in Patient with Neurofibromatosis Type I
The article describes the clinical signs of neurofibromatosis type I, in particular its bone manifestations. Also information on current approaches to diagnosis and surgical treatment of patients with neurofibromatosis t...
Osteoarthritis in Different Ecological Regions. The Message 2. Correlation with the State of Drinking Water
The aim of the work was to evaluate the clinical and pathogenetic links of osteoarthritis (OA) with the qualitative composition of the drinking water in zones of patients’ residence. Material and Methods. The observation...
Bone Metabolism and Osteoporosis in Oncological Practice
A review of the current literature and our own researches data are presented. They are demonstrated the existence of close connection between malignant tumors and bone metabolism disorders. It manifests by an increase in...
Osteopontin and osteocalcin in lung cancer
Background. Lung cancer (LC) occupies a leading position in the structure of cancer morbidity and is one of the leading causes of death. Search for effective approaches to assess the course of LC using informative criter...